COL10A1 and breast carcinoma: In particular, COL10A1 serves as a poor prognostic marker in bladder cancer (OS and DSS), brain cancer (OS), breast cancer (RFS and DFS), colorectal cancer (OS, DSS, and DFS), lung cancer (OS and RFS), ovarian cancer (OS and DFS) and soft tissue cancer (DFS).